Great f.y.i. Get hooked here!
CheckMate -743 is the first and only Phase 3 trial in which first-line immunotherapy treatment improved survival in patients with malignant pleural mesothelioma With these positive results, Opdivo plus Yervoy has now shown clinical benefit in six different tumor types, including durable,
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2020 second quarter financial results on Monday, August 10, 2020, before the market opens. Scott Tarriff, Chief Executive Officer, and Pete Meyers,
Japan Business Venture shifts focus to specialty assets and a portfolio of select generics that meet patients’ medical needs Remains positioned to address unmet patient needs in core therapeutic areas Will divest majority of current non-differentiated generics portfolio, as well as local
BLA submission based on results from pivotal Phase 2 KarMMa study evaluating ide-cel in heavily pre-treated patient population Companies are committed to working with the FDA to rapidly advance ide-cel through the regulatory review process PRINCETON, N.J., & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$BLUE #BMS—Bristol
Company earns score of 90 and recognized as a Best Place to Work for Disability Inclusion WHIPPANY, N.J.–(BUSINESS WIRE)–For the second consecutive year, Bayer U.S. was recognized as a Best Place to Work for Disability Inclusion, earning a score of 90 in
TRENTON, N.J. — Nowadays, invasion of one’s privacy is more accessible given the growth of social media and electronic devices everywhere; and this means greater protection for personal information. Hackers and identity thieves are inquisitive about the sources to personal information that